Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Days alive and out of hospital after treatment for oropharyngeal squamous cell carcinoma with primary transoral robotic surgery or radiotherapy - a prospective cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Distribution of microcrack surface density in the human otic capsule

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Manuscript title: the maxillary swing approach - the first Scandinavian experience

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Autologous fibrin sealant co-delivered with antibiotics is a robust method for topical antibiotic treatment after sinus surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Nordic results of cochlear implantation in adults: speech perception and patient reported outcomes

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. COVID-19 infection rate among tertiary referral center otorhinolaryngology healthcare workers

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Enhanced recovery after breast reconstruction with a pedicled Latissimus Dorsi flap-A prospective clinical study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Inflammatory response, fluid balance and outcome in emergency high-risk abdominal surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: With the rising incidence of oropharyngeal squamous cell cancer, there is a need to assess the burden of treatment.

AIMS/OBJECTIVES: This study assessed 'days alive and out of hospital' (DAOH) in a cohort of patients with oropharyngeal squamous cell carcinoma (OPSCC) treated with either transoral robotic surgery (TORS) or radiotherapy (RT).

MATERIAL AND METHODS: A prospective cohort study conducted between May 2017-June 2019. Primary outcome was DAOH in the first 30 days after treatment (DAOH30). The secondary outcome was DAOH180.

RESULTS: Forty-four patients were included, 31 treated with TORS and 13 with RT. Patients treated with TORS had a median DAOH30 of 25 (IQR 22.8-26) including a required four-day postoperative stay- and a median DAOH180 of 168 (IQR 163-171.3). In contrast, patients treated with RT had a median DAOH30 of 30 (IQR 26-30) and a DAOH180 of 143 days (IQR 135.5-149).

CONCLUSIONS AND SIGNIFICANCE: DAOH has not been examined in oropharyngeal cancer before. We found, patients overall spent 92.5% of the first 180 days alive and out of hospital. Patients treated with TORS had high DAOH30, which remained high in DAOH180, while patients treated with RT with reduced DAOH30, had reduced DAOH180 calling for further large-scale studies.

Original languageEnglish
JournalActa Oto-Laryngologica
Volume141
Issue number2
Pages (from-to)193-196
Number of pages4
ISSN0001-6489
DOIs
Publication statusPublished - Feb 2021

    Research areas

  • Days Alive and Out of Hospital, DAOH, oropharyngeal cancer, squamous cell carcinoma, TORS, radiotherapy

ID: 61215026